Document is current
Any future updates will be listed below
-
Authors
You, Benoit
Couraud, Sebastien
Ceruse, Philippe
Badet, Lionel
Paparel, Philippe
Durand, Alice
Guillet, Marielle
Merle, Philippe
Lescuyer, Gaelle
Philip, Charles-André
Ducray, Francois
Pioche, Mathieu
Karlin, Lionel
Lifante, Jean-Christophe
Glehen, Olivier
Bolze, Pierre-Adrien
Chauvenet, Marion
Langlois-Jacques, Carole
Subtil, Fabien
Piecyk, Marie
Carrot, Aurore
Joubert, Dominique
Prieur, Alexandre
Vire, Berengere
Calattini, Sara
Payen, Lea
-
Funding
Funding for this research was provided by:
Biodena Care
- License Information
-
More Information
Article History
Received: 11 March 2025
Accepted: 25 May 2025
First Online: 1 July 2025
Declarations
:
: All patients gave their consent and signed the informed consent. The protocol, the written information sheet and the consent form for the study obtained a favorable opinion from to ethics committee Ile de France VI on October 3rd 2018. This notification was transmitted to the French health authority ANSM. All Protocol amendments were approved by the same ethic committee.
: Not applicable.
: DJ, AP, and BV are employed by Biodena Care (Progastrin Manufacturing). All the other coauthors have no conflict of interest to disclose.
